Frequent Occurrence of Hypogonadotropic Hypogonadism in Type 2 Diabetes
The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Type 2 diabetes is associated with lower total testosterone (T) levels in cross-sectional studies. However, it is not known whether the defect is primary or secondary. We investigated the prevalence of hypogonadism in type 2 diabetes by measuring serum total T, free T (FT), SHBG, LH, FSH, and prolactin (PRL) in 103 type 2 diabetes patients. FT was measured by equilibrium dialysis. FT was also calculated by using T and SHBG (cFT). Hypogonadism was defined as low FT or cFT. The mean age was 54.7 +/- 1.1 yr, mean body mass index (BMI) was 33.4 +/- 0.8 kg/m(2), and mean HbA1c was 8.4 +/- 0.2%. The mean T was 12.19 +/- 0.50 nmol/liter (351.7 +/- 14.4 ng/dl), SHBG was 27.89 +/- 1.65 nmol/liter, and FT was 0.250 +/- 0.014 nmol/liter. Thirty-three percent of patients were hypogonadal. LH and FSH levels were significantly lower in the hypogonadal group compared with patients with normal FT levels (3.15 +/- 0.26 vs. 3.91 +/- 0.24 mIU/ml for LH and 4.25 +/- 0.45 vs. 5.53 +/- 0.40 mIU/ml for FSH; P < 0.05). There was a significant inverse correlation of BMI with FT (r = -0.382; P < 0.01) and T (r = -0.327; P < 0.01). SHBG correlated inversely with BMI (r = -0.267; P < 0.05) but positively with age (r = 0.538; P < 0.001) and T (r = 0.574; P < 0.001). FT correlated strongly with cFT (r = 0.919; P < 0.001) but not with SHBG. LH levels correlated positively with FT (r = 0.287; P < 0.05). We conclude that hypogonadotropic hypogonadism occurs commonly in type 2 diabetes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Importantly, Dhindsa et al. (9) demonstrated that 33% of men with type 2 diabetes had significantly lower levels of free testosterone measured by equilibrium dialysis, which is the widely accepted most clinically relevant assay for free testosterone.”
From Clinical and Biochemical Assessment of Hypogonadism in Men With Type 2 Diabetes (2007) · cites this paper as [9]
In the citing paper
“Furthermore, it has been reported that testosterone levels are lower in diabetic men compared with nondiabetic subjects (6 -9).”
From Clinical and Biochemical Assessment of Hypogonadism in Men With Type 2 Diabetes (2007) · cites this paper as [9]
In the citing paper
“A recent study has demonstrated that free testosterone levels, which are independent of SHBG, are low in one-third of diabetic men (9).”
From Clinical and Biochemical Assessment of Hypogonadism in Men With Type 2 Diabetes (2007) · cites this paper as [9]
In the citing paper
“Most of the studies in diabetic men have defined hypogonadism solely on the basis of testosterone levels (9).”
From Clinical and Biochemical Assessment of Hypogonadism in Men With Type 2 Diabetes (2007) · cites this paper as [9]
Citations
Cites
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041
Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
Hotamisligil, G. S., Shargill, N. S., & Spiegelman, B. M. (1993) · Science · doi:10.1126/science.7678183 · Cited by 7,518
A Critical Evaluation of Simple Methods for the Estimation of Free Testosterone in Serum
Vermeulen, A., Verdonck, L., & Kaufman, J. M. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.10.6079 · Cited by 3,824 · cited 1×
“(12) and using a computer program and web site address supplied by Dr.”
MethodLongitudinal Effects of Aging on Serum Total and Free Testosterone Levels in Healthy Men
Harman, S. M., Metter, E. J., Tobin, J. D., Pearson, J., & Blackman, M. R. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.2.7219 · Cited by 2,760 · cited 11×
“We compared the prevalence of hypogonadism in our study (using the same criteria as BLSA) across various age ranges with the prevalence from BLSA.”
ResultInfluentialRole of Brain Insulin Receptor in Control of Body Weight and Reproduction
Brüning, J. C., Gautam, D., Burks, D. J., Gillette, J., Schubert, M., Orban, P. C., Klein, R., Krone, W., Müller-Wieland, D., & Kahn, C. R. (2000) · Science · doi:10.1126/science.289.5487.2122 · Cited by 2,235
Feldman, H. A., Longcope, C., Derby, C. A., Johannes, C. B., Araujo, A. B., Coviello, A. D., Bremner, W. J., & McKinlay, J. B. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.2.8201 · Cited by 1,861 · cited 3×
“In the BLSA, the presence of cancer was associated with a greater decline in T levels than that observed with aging alone (23).”
BackgroundDUNN, J. F., NISULA, B. C., & RODBARD, D. (1981) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-53-1-58 · Cited by 1,238 · cited 1×
“In the blood of normal men, 44% of total T is bound to SHBG, 2% is unbound [free T (FT)], and 54% circulates bound to albumin and other proteins (9).”
BackgroundGRAY, A., FELDMAN, H. A., MCKINLAY, J. B., & LONGCOPE, C. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-73-5-1016 · Cited by 1,118 · cited 1×
“PRL levels remain constant or either increase or decrease slightly with age (18, 23).”
BackgroundTestosterone dose-response relationships in healthy young men
Bhasin, S., Woodhouse, L., Casaburi, R., Singh, A. B., Bhasin, D., Berman, N., Chen, X., Yarasheski, K. E., Magliano, L., Dzekov, C., et al. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.281.6.e1172 · Cited by 967 · cited 1×
“Serum T levels in the lower range of normal are able to maintain aspects of sexual functions, but muscle strength, muscle size, and fat-free mass increase progressively in a dose-dependent fashion with increase in circulating T concentrations even within the normal range (39, 40).”
BackgroundMorley, J. E., Kaiser, F. E., Perry, H. M., Patrick, P., Morley, P. M. K., Stauber, P. M., Vellas, B., Baumgartner, R. N., & Garry, P. J. (1997) · Metabolism · doi:10.1016/s0026-0495(97)90057-3 · Cited by 830 · cited 2×
“The increase in LH does not correlate with the decrease in T, suggesting an age-related alteration in this feedback mechanism (24, 25).”
Background
Cited by
Items 101–200 of 637
The many faces of testosterone
Bain, J. (2008) · Clinical Interventions in Aging · doi:10.2147/cia.s1417 · Cited by 112
“Dhindsa et al (2004) studied 103 male patients who had type 2 diabetes mellitus using free testosterone (done by equilibrium dialysis) or calculated free testosterone which takes SHBG levels into account.”
Diabetic Complications in Obese Type 2 Diabetic Rat Models
Katsuda, Y., Ohta, T., Miyajima, K., Kemmochi, Y., Sasase, T., Tong, B., Shinohara, M., & Yamada, T. (2014) · Experimental Animals · doi:10.1538/expanim.63.121 · Cited by 95
“Sexual dysfunction it was reported that subnormal free testosterone concentrations were related with inappropriately low luteinizing hormone (Lh) and follicle-stimulating hormone (Fsh) concentrations and a normal response to gonadotropin-releasing hormone (gnrh) of Lh and Fsh in type 2 diabetes [10, 13].”
BackgroundCorona, G., Mannucci, E., Forti, G., & Maggi, M. (2009) · International Journal of Andrology · doi:10.1111/j.1365-2605.2009.00965.x · Cited by 96
Testosterone and weight loss: the evidence
Traish, A. M. (2014) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0000000000000086 · Cited by 94
Corona, G., Mannucci, E., Petrone, L., Schulman, C., Balercia, G., Fisher, A. D., Chiarini, V., Forti, G., & Maggi, M. (2007) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2007.00498.x · Cited by 98
Hackett, G., Cole, N., Bhartia, M., Kennedy, D., Raju, J., Wilkinson, P., Saghir, A., & BLAST STUDY GROUP (2014) · International Journal of Clinical Practice · doi:10.1111/ijcp.12235 · Cited by 95
Effects of testosterone on Type 2 diabetes and components of the metabolic syndrome
JONES, T. H. (2010) · Journal of Diabetes · doi:10.1111/j.1753-0407.2010.00085.x · Cited by 92
Prevalence of low testosterone levels in men with type 2 diabetes mellitus: a cross-sectional study
Al Hayek, A., Khader, Y., Jafal, S., Khawaja, N., Robert, A., & Ajlouni, K. (2013) · Journal of Family and Community Medicine · doi:10.4103/2230-8229.122006 · Cited by 94
“[41] However, a study reported that the presence of LST was not entirely dependent upon obesity because 25% of nonobese patients (31% of lean and 21% of overweight) also had HG.[13] Table 3: Prevalence of low serum testosterone level (total testosterone <3 ng/ml) for patients with type 2 diabetes mellitus according to…”
Endocrine causes of nonalcoholic fatty liver disease
Marino, L., & Jornayvaz, F. R. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i39.11053 · Cited by 100
Ahn, S. W., Gang, G.-T., Kim, Y. D., Ahn, R.-S., Harris, R. A., Lee, C.-H., & Choi, H.-S. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.451773 · Cited by 84
“Because testosterone concentration is affected by LH and FSH levels via the hypothalamicpituitary-gonadal axis (1, 2), we measured LH and FSH.”
BackgroundBody composition, metabolic syndrome and type 2 diabetes in Klinefelter syndrome
Gravholt, C. H., Jensen, A. S., Høst, C., & Bojesen, A. (2011) · Acta Paediatrica · doi:10.1111/j.1651-2227.2011.02233.x · Cited by 86
“In addition, lower levels of testosterone, free testosterone and SHBG have been found in both obese (35) and diabetic men (36).”
BackgroundMechanisms underlying the metabolic actions of testosterone in humans: A narrative review
Dandona, P., Dhindsa, S., Ghanim, H., & Saad, F. (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14206 · Cited by 95
“A quarter of obese men and a third of men with type 2 diabetes have subnormal free testosterone concentrations.(9,36) The insulin-sensitizing effect of testosterone therapy is, therefore, especially pertinent to this population.”
BackgroundSelf-citationKapoor, D., Clarke, S., Channer, K. S., & Jones, T. H. (2007) · International Journal of Andrology · doi:10.1111/j.1365-2605.2007.00744.x · Cited by 90
Diagnosis and treatment of hypogonadism in men
Bhasin, S., & Basaria, S. S. (2011) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2010.12.002 · Cited by 94
Obesity, type 2 diabetes, and testosterone in ageing men
Wittert, G., & Grossmann, M. (2022) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-022-09746-5 · Cited by 101
Testosterone deficiency in men with Type 2 diabetes: pathophysiology and treatment
Gianatti, E., & Grossmann, M. (2019) · Diabetic Medicine · doi:10.1111/dme.13977 · Cited by 91
Šimonienė, D., Platūkiene, A., Prakapienė, E., Radzevičienė, L., & Veličkiene, D. (2020) · Diabetes Therapy · doi:10.1007/s13300-019-00729-5 · Cited by 80
Sexual dysfunction in men with type 2 diabetes
Isidro, M. L. (2012) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2011-130069 · Cited by 91
A Comprehensive Review of Metabolic Syndrome Affecting Erectile Dysfunction
Kaya‐Sezginer, E., Sikka, S. C., & Gür, S. (2015) · The Journal of Sexual Medicine · doi:10.1111/jsm.12828 · Cited by 88
Testosterone and the aging male: To treat or not to treat?
Bain, J. (2010) · Maturitas · doi:10.1016/j.maturitas.2010.01.009 · Cited by 91
Determinants of Sexual Function among Women with Type 2 Diabetes in a Nigerian Population
Olarinoye, J. K., & Olarinoye, A. O. (2008) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2007.00649.x · Cited by 84
Sex hormones, obesity and type 2 diabetes: is there a link?
Gambineri, A., & Pelusi, C. (2018) · Endocrine Connections · doi:10.1530/ec-18-0450 · Cited by 92
Haider, K. S., Haider, A., Saad, F., Doros, G., Hanefeld, M., Dhindsa, S., Dandona, P., & Traish, A. (2020) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14122 · Cited by 82
“Dhindsa et al.1 first described the syndrome of hypogonadotropic hypogonadism (HH) in men with T2DM.”
BackgroundSelf-citationTestosterone Therapy in Erectile Dysfunction and Hypogonadism
Shabsigh, R. (2005) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2005.00139.x · Cited by 81
Diet-induced obesity and low testosterone increase neuroinflammation and impair neural function
Jayaraman, A., Lent-Schochet, D., & Pike, C. J. (2014) · Journal of Neuroinflammation · doi:10.1186/s12974-014-0162-y · Cited by 78
“On the other hand, central obesity and T2D reduce testosterone levels [34-37].”
BackgroundA Comprehensive Review of Neuronal Changes in Diabetics
Luna, R., Manjunatha, R. T., Bollu, B., Jhaveri, S., Avanthika, C., Reddy, N., Saha, T., & Gandhi, F. R. (2021) · Cureus · doi:10.7759/cureus.19142 · Cited by 93
“According to studies, the prevalence of hypogonadism in men with T2DM varies from 20% to 60% [156].”
BackgroundInder, W. J., Jang, C., Obeyesekere, V. R., & ALFORD, F. P. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03683.x · Cited by 82
Testosterone concentrations in young pubertal and post-pubertal obese males
Mogri, M., Dhindsa, S., Quattrin, T., Ghanim, H., & Dandona, P. (2013) · Clinical Endocrinology · doi:10.1111/cen.12018 · Cited by 79
Self-citationThe Laboratory Diagnosis of Testosterone Deficiency
Paduch, D. A., Brannigan, R. E., Fuchs, E. F., Kim, E. D., Marmar, J. L., & Sandlow, J. I. (2014) · Urology · doi:10.1016/j.urology.2013.12.024 · Cited by 83
“30 Hypogonadotropic hypogonadism occurs frequently in men with T2DM and obesity.(31) Measurement of T in men with metabolic syndrome and symptoms of T deficiency have been suggested, but effect of weight loss on diagnosis of hypogonadism and the utility of androgen replacement therapy in symptomatic men continues to b…”
BackgroundAndrogens, diabetes and prostate cancer
Grossmann, M., & Wittert, G. (2012) · Endocrine Related Cancer · doi:10.1530/erc-12-0067 · Cited by 85
“(DiGiovanni et al. 2000), and mice with global or liver-specific inactivation of IGF1 show reduced prostate size and reduced androgen-dependent prostate growth (Svensson et al. 2008).”
Giannetta, E., Gianfrilli, D., Barbagallo, F., Isidori, A. M., & Lenzi, A. (2012) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2011.12.005 · Cited by 79
TRANSITION IN ENDOCRINOLOGY: Hypogonadism in adolescence
Dwyer, A. A., Phan-Hug, F., Hauschild, M., Elowe-Gruau, E., & Pitteloud, N. (2015) · European Journal of Endocrinology · doi:10.1530/eje-14-0947 · Cited by 73
Male hypogonadism. Part I: Epidemiology of hypogonadism
Seftel, A. D. (2005) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3901397 · Cited by 79
Testosterone Associations with Erectile Dysfunction, Diabetes, and the Metabolic Syndrome
Jones, T. H. (2007) · European Urology Supplements · doi:10.1016/j.eursup.2007.07.002 · Cited by 80
The practical management of testosterone deficiency in men
Aversa, A., & Morgentaler, A. (2015) · Nature Reviews Urology · doi:10.1038/nrurol.2015.238 · Cited by 78
Collier, A., Ghosh, S., McGlynn, B., & Hollins, G. (2012) · American Journal of Clinical Oncology · doi:10.1097/coc.0b013e318201a406 · Cited by 74
“It is reported that androgen deficiency in type 2 diabetes is commonly associated with hypogonadotropic hypogonadism.(27) It is suggested that insulin resistance determines a reduction in insulin action in the thalamus leading to hypogonadotropic hypogonadism.”
BackgroundDiabetes, obesity, and erectile dysfunction
Tamler, R. (2009) · Gender Medicine · doi:10.1016/j.genm.2008.12.003 · Cited by 78
Rato, L., Alves, M. G., Duarte, A. I., Santos, M. S., Moreira, P. I., Cavaco, J. E. B., & Oliveira, P. F. (2015) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2015.07.001 · Cited by 73
“This is crucial since the significant reduction of 102 testosterone induced by the diabetic states is contributing to a decline in male 103 reproductive health (Corona et al., 2011; Dhindsa et al., 2004; Pitteloud et al., 2005; 104 Rato et al., 2013; Rato et al., 2014b).”
BackgroundTestosterone and Erectile Dysfunction
Yassin, A. A., & Saad, F. (2008) · Journal of Andrology · doi:10.2164/jandrol.107.004630 · Cited by 78
Treatment of Hypogonadism with Testosterone in Patients with Type 2 Diabetes Mellitus
Gopal, R. A., Bothra, N., Acharya, S. V., Ganesh, H. K., Bandgar, T., Menon, P. S., & Shah, N. S. (2010) · Endocrine Practice · doi:10.4158/ep09355.or · Cited by 76
Metabolic syndrome and infertility in men
Morrison, C. D., & Brannigan, R. E. (2014) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2014.10.006 · Cited by 76
SHABSIGH, R., RAJFER, J., AVERSA, A., TRAISH, A. M., YASSIN, A., KALINCHENKO, S. Y., & BUVAT, J. (2006) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2006.01101.x · Cited by 73
Gandhi, J., Dagur, G., Warren, K., Smith, N. L., Sheynkin, Y., Zumbo, A., & Khan, S. A. (2017) · Current Diabetes Reviews · doi:10.2174/1573399813666161122124017 · Cited by 75
Low Serum Testosterone Concentration in Middle-aged Men with Type 2 Diabetes
FUKUI, M., SOH, J., TANAKA, M., KITAGAWA, Y., HASEGAWA, G., YOSHIKAWA, T., MIKI, T., & NAKAMURA, N. (2007) · Endocrine Journal · doi:10.1507/endocrj.k07-077 · Cited by 73
“[13] demonstrating serum LH concentrations correlated positively with serum free testosterone concentrations (hypogonadotropic hypogonadism) in men with type 2 diabetes.”
Gianatti, E. J., Dupuis, P., Hoermann, R., Zajac, J. D., & Grossmann, M. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1872 · Cited by 67
“78 Sexual desire question 17 AMS n 44 n 41 0 weeks 2 [1, 3] 2 [1, 3] 18 weeks 2 [1, 2] 2 [1, 3] 40 weeks 1 [1, 3] 2 [1, 3.”
Insulin and Leptin Signaling Interact in the Mouse Kiss1 Neuron during the Peripubertal Period
Qiu, X., Dao, H., Wang, M., Heston, A., Garcia, K. M., Sangal, A., Dowling, A. R., Faulkner, L. D., Molitor, S. C., Elias, C. F., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0121974 · Cited by 64
“While obesity and insulin resistance are each independently associated with lower plasma testosterone levels [9, 10], obese men with T2DM appear to be at particularly high risk [11, 12].”
BackgroundTestosterone a key factor in gender related metabolic syndrome
Bianchi, V. E., & Locatelli, V. (2018) · Obesity Reviews · doi:10.1111/obr.12633 · Cited by 78
The complex association between metabolic syndrome and male hypogonadism
Dimopoulou, C., Goulis, D. G., Corona, G., & Maggi, M. (2018) · Metabolism · doi:10.1016/j.metabol.2018.03.024 · Cited by 70
Phosphodiesterase 5 Inhibitors in the Treatment of Erectile Dysfunction
Aversa, A., Bruzziches, R., Pili, M., & Spera, G. (2006) · Current Pharmaceutical Design · doi:10.2174/138161206778343046 · Cited by 71
“A high prevalence of ED in patients with diabetes has been attributed mainly to vascular and neurologic conditions, but also to hypogonadism [49], which has been observed to occur commonly with type 2 diabetes [50], and to result from metabolic syndrome in middle-aged men [51].”
BackgroundVeldhuis, J., Yang, R., Roelfsema, F., & Takahashi, P. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3611 · Cited by 65
Metabolic syndrome and sexual dysfunction
Schulster, M. L., Liang, S. E., & Najari, B. B. (2017) · Current Opinion in Urology · doi:10.1097/mou.0000000000000426 · Cited by 70
Noto, H., Tsujimoto, T., & Noda, M. (2011) · Journal of Diabetes Investigation · doi:10.1111/j.2040-1124.2011.00183.x · Cited by 65
KotliÅ„ska-Lemieszek, A., & Zylicz, Z. (2022) · Drug Design Development and Therapy · doi:10.2147/dddt.s342409 · Cited by 74
“Using corticosteroids or metoclopramide may also cause hypogonadism.(184,185) Patients may use other CNS depressants associated with an increased risk of fallrelated fractures (for example, antipsychotic agents, benzodiazepines and antidepressants).”
Frequent Occurrence of Hypogonadotropic Hypogonadism in Type 2 Diabetes
Morton, A. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2310 · Cited by 62
Low testosterone and anaemia in men with type 2 diabetes
Grossmann, M., Panagiotopolous, S., Sharpe, K., MacIsaac, R. J., Clarke, S., Zajac, J. D., Jerums, G., & Thomas, M. C. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03357.x · Cited by 61
Therapy Insight: sexual and bladder dysfunction associated with diabetes mellitus
Fedele, D. (2005) · Nature Clinical Practice Urology · doi:10.1038/ncpuro0211 · Cited by 61
“A study published in 2004 reported that hypogonadotropic hypogonadism occurs frequently in men with type 2 diabetes, which is another important factor to consider in the etiology of ED in this group of men”
Ryan, J., & Gajraj, J. (2012) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2011.12.001 · Cited by 63
Prevalence of testosterone deficiency among aging men with and without morbidities
Ērenpreiss, J., Fodina, V., Požarska, R., Zubkova, K., Dudorova, A., & Požarskis, A. (2019) · The Aging Male · doi:10.1080/13685538.2019.1621832 · Cited by 63
“05) exhibited also other morbidities as similarly demonstrated in previous studies: arterial hypertension [7,26,27], obesity [9,10,28], type II diabetes [6,29,30], and metabolic syndrome [26,31–33].”
ResultKapoor, D., Channer, K. S., & Jones, T. H. (2008) · Diabetes and Vascular Disease Research · doi:10.3132/dvdr.2008.022 · Cited by 58
“This is confirmed by studies that have shown approximately one third of men with type 2 diabetes were hypogonadal by FT assayed by equilibrium dialysis and BT measured by ammonium sulphate precipitation.(6,7) Rosiglitazone, as in this study, is known to increase the BMI.”
ResultGregorič, N., Šikonja, J., Janež, A., & Jensterle, M. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16042 · Cited by 61
Why Men's Hearts Break: Cardiovascular Effects of Sex Steroids
Choi, B. G., & McLaughlin, M. A. (2007) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2007.03.011 · Cited by 63
Sathyapalan, T., Rigby, A. S., Bhasin, S., Thatcher, N. J., Kilpatrick, E. S., & Atkin, S. L. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2875 · Cited by 57
Kamenov, Z. A., & Traykov, L. D. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-5441-0_15 · Cited by 58
Cayetano-Alcaráz, A. A., Tharakan, T., Chen, R., Sofikitis, N., & Minhas, S. (2022) · Andrology · doi:10.1111/andr.13257 · Cited by 64
Do low testosterone levels contribute to ill-health during male ageing?
Yeap, B. B., de Araújo, A. B., & Wittert, G. (2012) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408363.2012.725461 · Cited by 53
Mechanisms of obesity-induced male infertility
Phillips, K. P., & Tanphaichitr, N. (2010) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.09.65 · Cited by 55
Traish, A. M. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-70178-3_22 · Cited by 58
Kapoor, D., & Jones, T. H. (2008) · Drugs & Aging · doi:10.2165/00002512-200825050-00001 · Cited by 57
Farias, J. M., Tinetti, M., Khoury, M. C., & Umpierrez, G. E. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2585 · Cited by 52
“Dhindsa et al (14) reported that up to one-third of patients with T2D have low serum T concentrations with clinical evidence of hypogonadism.”
BackgroundAdverse health effects of testosterone deficiency (TD) in men
Traish, A. M. (2014) · Steroids · doi:10.1016/j.steroids.2014.05.010 · Cited by 53
Environmental Toxins and Infertility.
Pizzorno, J. E. (2018) · Europe PMC (PubMed Central) · Cited by 51
Predicting Biochemical Response to Clomiphene Citrate in Men with Hypogonadism
Mazzola, C. R., Katz, D. J., Loghmanieh, N., Nelson, C. J., & Mulhall, J. P. (2014) · The Journal of Sexual Medicine · doi:10.1111/jsm.12592 · Cited by 50
Biochemical hypogonadism in men with type 2 diabetes in primary care practice
Hackett, G. I., Cole, N. S., Deshpande, A. A., Popple, M. D., Kennedy, D., & Wilkinson, P. (2009) · The British Journal of Diabetes & Vascular Disease · doi:10.1177/1474651409342635 · Cited by 49
Earlier development of diabetic neuropathy in men than in women with type 2 diabetes mellitus
Kamenov, Z. A., Parapunova, R., & Georgieva, R. (2010) · Gender Medicine · doi:10.1016/j.genm.2010.11.001 · Cited by 53
The Effects of Hypogonadism on Body Composition and Bone Mineral Density in Type 2 Diabetic Patients
Dhindsa, S., Bhatia, V., Dhindsa, G., Chaudhuri, A., Gollapudi, G. M., & Dandona, P. (2007) · Diabetes Care · doi:10.2337/dc07-0337 · Cited by 47
Self-citationDhindsa, S., Ghanim, H., Batra, M., Kuhadiya, N. D., Abuaysheh, S., Green, K., Makdissi, A., Chaudhuri, A., & Dandona, P. (2016) · Clinical Endocrinology · doi:10.1111/cen.13130 · Cited by 49
“Introduction A third of men of men with type 2 diabetes have subnormal free testosterone concentrations in association with inappropriately low LH and FSH concentrations (1-4).”
BackgroundSelf-citationSecondary male hypogonadism: A prevalent but overlooked comorbidity of obesity
Fernandez-Garcia, J.-C., Molina‐Vega, M., Muñoz-Garach, A., Damas-Fuentes, M., & Tinahones, F. J. (2018) · Asian Journal of Andrology · doi:10.4103/aja.aja_44_18 · Cited by 55
Testosterone Recovery Profiles After Cessation of Androgen Deprivation Therapy for Prostate Cancer
Nascimento, B., Miranda, E., Jenkins, L. C., Benfante, N. E., Schofield, E., & Mulhall, J. P. (2019) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2019.03.273 · Cited by 51
Characterization of the male ApcMin/+ mouse as a hypogonadism model related to cancer cachexia
White, J. P., Puppa, M. J., Narsale, A., & Carson, J. A. (2013) · Biology Open · doi:10.1242/bio.20136544 · Cited by 47
Diabetes, medical comorbidities and couple fecundity
Eisenberg, M. L., Sundaram, R., Maisog, J. M., & Louis, G. M. B. (2016) · Human Reproduction · doi:10.1093/humrep/dew200 · Cited by 49
“Authors have attributed impaired fertility among men with diabetes to alterations in the hypothalamic–pituitary–gonadal axis or increased reactive oxygen specimens in the ejaculates of diabetic men as biological explanations (Lopez-Alvarenga et al., 2002; Dhindsa et al., 2004; Agbaje et al., 2007).”
BackgroundHypogonadotropic Hypogonadism in Men with Type 2 Diabetes
Dandona, P., Dhindsa, S., Chandel, A., & Chaudhuri, A. (2009) · Postgraduate Medicine · doi:10.3810/pgm.2009.05.2001 · Cited by 47
“We have shown that glycosylated hemoglobin (HbA 1c ) is not associated with the T concentrations, but increased body weight in men with type 2 diabetes is associated with lower T concentrations.(10) This article describes the association of HH with type 2 diabetes and obesity, the pathophysiological mechanisms underly…”
BackgroundMethodSelf-citationBenefits and Health Implications of Testosterone Therapy in Men With Testosterone Deficiency.
Traish, A. (2018) · Sexual Medicine Reviews · doi:10.1016/j.sxmr.2017.10.001 · Cited by 44
Nasiri, K., Akbari, A., Nimrouzi, M., Ruyvaran, M., & Mohamadian, A. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114139 · Cited by 48
Biswas, M., Hampton, D., Newcombe, R. G., & Rees, D. A. (2012) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04196.x · Cited by 46
Al Khaja, K. A. J., Sequeira, R. P., Alkhaja, A. K., & Damanhori, A. H. H. (2016) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248415598321 · Cited by 46
Evaluation of the hypothalamic‐pituitary‐gonadal axis in eugonadal men with type 2 diabetes mellitus
Costanzo, P., Suárez, S. M., Scaglia, H. E., Zylbersztein, C., Litwak, L., & Knoblovits, P. (2013) · Andrology · doi:10.1111/j.2047-2927.2013.00163.x · Cited by 48
“INTRODUCTION Several studies have shown that men with type 2 diabetes mellitus (DM2) have significantly lower testosterone (T) levels and a higher prevalence of hypogonadism than non-diabetic men (Dhindsa et al., 2004; Ding et al., 2006; Kapoor et al., 2007; Grossmann et al., 2008; Corona et al., 2011).”
BackgroundMethodInfluentialMaggio, M. G., Vita, F. D., Fisichella, A., Lauretani, F., Ticinesi, A., Ceresini, G., Cappola, A. R., Ferrucci, L., & Ceda, G. P. (2015) · International Journal of Endocrinology · doi:10.1155/2015/292574 · Cited by 49
“Primary hypogonadism frequently occurs in elderly patients, while secondary hypogonadism is more commonly diagnosed in middle-aged men with multimorbidity including type 2 diabetes mellitus [71, 104, 105].”
BackgroundIL-6, cancer and cachexia: metabolic dysfunction creates the perfect storm
White, J. P. (2017) · Translational Cancer Research · doi:10.21037/tcr.2017.03.52 · Cited by 46
“Several human diseases associated with a loss of lean body mass such as diabetes (47), chronic obstructive pulmonary disorder (COPD) (48), HIV-AIDs (49) and cancer (50) have reported a reduction in circulating testosterone in patients.”
BackgroundLate‐onset hypogonadism and lifestyle‐related metabolic disorders
Braga, P. C., Pereira, S., Ribeiro, J. C., Sousa, M., Monteiro, M. P., Oliveira, P. F., & Alves, M. G. (2020) · Andrology · doi:10.1111/andr.12765 · Cited by 46
Impact of COVID 19 on erectile function
Adeyemi, D. H., Odetayo, A. F., Hamed, M. A., & Akhigbe, R. E. (2022) · The Aging Male · doi:10.1080/13685538.2022.2104833 · Cited by 47
Testosterone, diabetes mellitus, and the metabolic syndrome
Spark, R. F. (2007) · Current Urology Reports · doi:10.1007/s11934-007-0050-4 · Cited by 46
Yaturu, S. (2009) · Journal of Diabetes · doi:10.1111/j.1753-0407.2009.00049.x · Cited by 51
“Hypogonadism has been reported to occur in as many as one-third of men with Type 2 diabetes.(54) A metaanalysis and systematic review of 43 studies including 6427 men suggested the existence of an inverse association between plasma testosterone and risk of Type 2 diabetes.”
BackgroundHypogonadism, Type-2 Diabetes Mellitus, and Bone Health: A Narrative Review
Russo, V., Chen, R., & Armamento-Villareal, R. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.607240 · Cited by 38
“showing that as much as 75% of men with T2DM have either low or normal luteinizing hormone (LH) or follicle stimulating hormone (FSH) or both indicating suppression of the hypothalamic-pituitary-gonadal axis likely from chronic hyperglycemia (8).”
BackgroundMethodInfluentialYaman, Ö., Akand, M., Gürsoy, A., Erdoğan, M. F., & Anafarta, K. (2006) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2006.00221.x · Cited by 43
Kelsey, M. M., Harwood, J. E. F., Travers, S. H., Zeitler, P. S., & Nadeau, K. J. (2010) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2010.202 · Cited by 44
IL-1 Antagonism in men with metabolic syndrome and low testosterone: a randomized clinical trial
Ebrahimi, F., Urwyler, S. A., Straumann, S., Doerpfeld, S., Bernasconi, L., Neyer, P., Schuetz, P., Mueller, B., Donath, M. Y., & Christ-Crain, M. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00739 · Cited by 42
Williams, G. P. (2010) · European Journal of Cancer Prevention · doi:10.1097/cej.0b013e328338f7d2 · Cited by 48
“This pattern of raised free oestradiol levels (Ding et al., 2006) and low testosterone levels (Dhindsa et al., 2004; Osuna et al., 2006) is commonly seen in type 2 diabetes.”
BackgroundBanerjee, A., Anuradha, A., Mukherjee, K., & Krishna, A. (2014) · Journal of Experimental Zoology Part A Ecological Genetics and Physiology · doi:10.1002/jez.1881 · Cited by 43
“Besides aging, the increasing incidence of obesity and diabetes mellitus may also lead to an increased incidence of secondary hypogonadism (Dhindsa et al., 2004).”
BackgroundGhanim, H., Dhindsa, S., Abuaysheh, S., Batra, M., Kuhadiya, N. D., Makdissi, A., Chaudhuri, A., & Dandona, P. (2018) · European Journal of Endocrinology · doi:10.1530/eje-17-0673 · Cited by 39
Self-citationGhanim, H., Dhindsa, S., Batra, M., Green, K., Abuaysheh, S., Kuhadiya, N. D., Makdissi, A., Chaudhuri, A., & Dandona, P. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01832 · Cited by 41
Self-citation
Metadata
- Authors
- Dhindsa, S., Prabhakar, S., Sethi, M., Bandyopadhyay, A., Chaudhuri, A., & Dandona, P.
- Affiliations
- Kaleida Health (US)
- Corresponding author
- Dandona, Paresh
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2004-11
- Volume
- 89
- Issue
- 11
- Pages
- 5462-5468
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2161417745
- Semantic Scholar
- 7eedeed5e563a3df27e91e79ee34ce6e496a93e3
- Cited by
- 631
- References
- 44
- Citations by year
- 2026: 18 · 2025: 16 · 2024: 17 · 2023: 14 · 2022: 24 · 2021: 37 · 2020: 19 · 2019: 27 · 2018: 40 · 2017: 36 · 2016: 37 · 2015: 36 · 2014: 42 · 2013: 43 · 2012: 38
- FWCI
- 9.75
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- type 2 diabetes, testosterone, free testosterone, sex hormone-binding globulin, luteinizing hormone, follicle-stimulating hormone, prolactin, body mass index, prevalence, hyperandrogenism, insulin resistance, HbA1c
- MeSH terms
- Adult, Age Factors, Aged, Aged, 80 and over, Diabetes Mellitus, Type 2, Follicle Stimulating Hormone, Humans, Hypogonadism, Luteinizing Hormone, Male, Middle Aged, Sex Hormone-Binding Globulin, Testosterone
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.